Trial Condition(s):

Multiple Sclerosis

Study of Betaferon adherence in patients with multiple sclerosis treated with interferon beta-1b (ADHERENCE)

Bayer Identifier:

2008/01880

ClinicalTrials.gov Identifier:

NCT03408093

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The primary objective of the study is to evaluate the adherence to the treatment with interferon beta-1b, in patients diagnosed with isolated syndrome (CIS), relapsing-remitting multiple sclerosis (RRMS), or secondary progressive multiple sclerosis (SPMS) who had more than 6 months in treatment.

Inclusion Criteria
- Patients with relapsing-remitting MS (RRMS), secondary progressive MS (SPMS) or patients with a first outbreak or clinically isolated syndrome (CIS) that carry more than 6 months in treatment with interferon beta-1b
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
120
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design